Morgan Stanley Keeps Overweight Rating on CrowdStrike (CRWD)
Morgan Stanley lowered its price target on CrowdStrike (CRWD) to $172 from $172.50, while keeping an Overweight rating. The minor adjustment came a day before Benchmark raised its own target.
Key Numbers
Morgan Stanley lowered its price target on CrowdStrike (CRWD) to $172 from $172.50, while maintaining an Overweight rating. The update was made on July 7, 2026, according to a report by Insider Monkey.
Rating Change
- Previous Rating: Overweight
- Current Rating: Overweight
- Previous Price Target: $172.50
- New Price Target: $172
Analyst Rationale
The report did not specify reasons for the slight price target cut. However, maintaining the Overweight rating suggests a continued positive outlook on the stock, likely due to CrowdStrike's strong fundamentals in the cybersecurity sector.
Context
On July 8, the day after Morgan Stanley's update, Benchmark raised its price target on CrowdStrike (the new figure was not disclosed). This divergence highlights varying analyst estimates.
CrowdStrike is listed among the 15 Best NASDAQ 100 Stocks to Buy Other Than SpaceX, per Insider Monkey's analysis.
What to Make of It
The minor price target reduction does not signal a fundamental change in the stock's outlook. Investors are advised to monitor other analyst updates and the company's financial performance.
Frequently Asked Questions
Found this useful? Share it